These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22434761)

  • 1. Response to 'human adenovirus-36 and childhood obesity'.
    Goossens VJ; Bruggeman CA
    Pediatr Obes; 2012 Apr; 7(2):e19-20. PubMed ID: 22434761
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenovirus-36 and obesity.
    Atkinson RL
    Pediatr Obes; 2012 Apr; 7(2):e18-9. PubMed ID: 22434760
    [No Abstract]   [Full Text] [Related]  

  • 3. Human adenovirus-36 and non-alcoholic fatty liver disease.
    Atkinson RL
    Liver Int; 2010 Feb; 30(2):164-5. PubMed ID: 20456035
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of infection with adenovirus-36 in Belgium and Holland and association with obesity.
    Atkinson RL
    Obesity (Silver Spring); 2011 Jan; 19(1):2; author reply 3. PubMed ID: 21187841
    [No Abstract]   [Full Text] [Related]  

  • 5. Human adenovirus-36 antibody status is associated with obesity in children.
    Atkinson RL; Lee I; Shin HJ; He J
    Int J Pediatr Obes; 2010 Apr; 5(2):157-60. PubMed ID: 19593728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of adenovirus types 3 and 7 antibodies in Singapore.
    Nishio O; Matsui K; Goh KT; Matsunaga Y; Inouye S
    Jpn J Infect Dis; 2001 Jun; 54(3):128-9. PubMed ID: 11544409
    [No Abstract]   [Full Text] [Related]  

  • 7. Human adenovirus-36 and childhood obesity.
    Atkinson RL
    Int J Pediatr Obes; 2011 Sep; 6 Suppl 1():2-6. PubMed ID: 21905809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus 36 infection and obesity.
    Esposito S; Preti V; Consolo S; Nazzari E; Principi N
    J Clin Virol; 2012 Oct; 55(2):95-100. PubMed ID: 22771001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frequency of adenovirus group complement-specific antibodies in children].
    Söyletir G; Us D; Cerikcioğlu N; Babacan F
    Mikrobiyol Bul; 1990 Jan; 24(1):16-9. PubMed ID: 2283960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is obesity an infectious disease?
    Powledge TM
    Lancet Infect Dis; 2004 Oct; 4(10):599. PubMed ID: 15470763
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of adenovirus 36 as a risk factor in obesity: the first clinical study made in the fatty tissues of adults in Turkey.
    Ergin S; Altan E; Pilanci O; Sirekbasan S; Cortuk O; Cizmecigil U; Ersin I; Elbey H; Dinc HO; Habip Z; Turan N; Arinci A; Richt JA; Goossens VJ; Karakullukcu A; Kocak BT; Saribas S; Koksal S; Yilmaz H; Kocazeybek B
    Microb Pathog; 2015 Mar; 80():57-62. PubMed ID: 25720551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease.
    Trovato GM; Martines GF; Garozzo A; Tonzuso A; Timpanaro R; Pirri C; Trovato FM; Catalano D
    Liver Int; 2010 Feb; 30(2):184-90. PubMed ID: 19840251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-36 antibody status & BMI comparison among obese Missouri adolescents.
    Tosh AK; Broy-Aschenbrenner A; El Khatib J; Ge B
    Mo Med; 2012; 109(5):402-3. PubMed ID: 23097948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of neutralizing antibodies to adenovirus type 5 among children in India: implications for recombinant adenovirus-based vaccines.
    Appaiahgari MB; Pandey RM; Vrati S
    Clin Vaccine Immunol; 2007 Aug; 14(8):1053-5. PubMed ID: 17596429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa.
    Thorner AR; Vogels R; Kaspers J; Weverling GJ; Holterman L; Lemckert AA; Dilraj A; McNally LM; Jeena PM; Jepsen S; Abbink P; Nanda A; Swanson PE; Bates AT; O'Brien KL; Havenga MJ; Goudsmit J; Barouch DH
    J Clin Microbiol; 2006 Oct; 44(10):3781-3. PubMed ID: 17021110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.
    Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B
    J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seroepidemiological study of conjunctivitis related adenoviruses].
    Aoki K; Sawada H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):181-6. PubMed ID: 3037868
    [No Abstract]   [Full Text] [Related]  

  • 18. Emergence of adenovirus type 14 in US military recruits--a new challenge.
    Binn LN; Sanchez JL; Gaydos JC
    J Infect Dis; 2007 Nov; 196(10):1436-7. PubMed ID: 18008220
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemic periodicity of adenovirus type 3 and 7 pneumonia in infants and children].
    Fu WY
    Zhonghua Yi Xue Za Zhi; 1985 Oct; 65(10):580-3. PubMed ID: 3008963
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevalence of antibodies to adenovirus serotype 5 in an adult Indian population and implications for adenovirus vector vaccines.
    Pilankatta R; Chawla T; Khanna N; Swaminathan S
    J Med Virol; 2010 Mar; 82(3):407-14. PubMed ID: 20087930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.